Page last updated: 2024-11-05

tolazoline and Psoriasis

tolazoline has been researched along with Psoriasis in 1 studies

Tolazoline: A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.
tolazoline : A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group.

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maucher, OM1
Brehm, K1

Trials

1 trial available for tolazoline and Psoriasis

ArticleYear
[Corticosteroid effect and vasoconstriction. 2. Influencing the antipsoriatic corticosteroid effect by suppression of vasoconstriction].
    Arzneimittel-Forschung, 1972, Volume: 22, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Clinical Trials as Topic; Female; Fluocinolone Acetonide; Granulatio

1972